CB Insights – AI Drug Discovery: Scouting Reports
Summary
The main topic of the report is the use of artificial intelligence (AI) in drug discovery.
The report contains scouting reports on 10 companies developing AI for drug discovery, including discovery engines and software platforms. Examples of key findings include: 1910 Genetics uses a multimodal AI platform to accelerate drug discovery, partnering with companies like Microsoft and Accenture. The company demonstrates early commercial validation, with revenue of $5M in 2024 and a forecast of $5.5M in 2025. 3BIGS is a South Korean company providing AI-powered big data analysis platforms for next-generation sequencing and microbiome analysis.
Region:
Published:
Author(s):
Language:
Tech drivers:
Geopolitical drivers:
Found an inaccuracy in the description? Let us know 🙌
